These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8729171)

  • 1. Fatty acids and insulin resistance.
    Boden G
    Diabetes Care; 1996 Apr; 19(4):394-5. PubMed ID: 8729171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.
    Chen YD; Golay A; Swislocki AL; Reaven GM
    J Clin Endocrinol Metab; 1987 Jan; 64(1):17-21. PubMed ID: 3782431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between free fatty acids and glucose metabolism.
    Boden G
    Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):545-9. PubMed ID: 12172479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
    Boden G; Chen X
    J Clin Invest; 1995 Sep; 96(3):1261-8. PubMed ID: 7657800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
    Basu A; Caumo A; Bettini F; Gelisio A; Alzaid A; Cobelli C; Rizza RA
    Diabetes; 1997 Mar; 46(3):421-32. PubMed ID: 9032098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acids, insulin resistance, and type 2 diabetes mellitus.
    Boden G
    Proc Assoc Am Physicians; 1999; 111(3):241-8. PubMed ID: 10354364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids (FFA), a link between obesity and insulin resistance.
    Boden G
    Front Biosci; 1998 Feb; 3():d169-75. PubMed ID: 9450985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
    Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
    J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans.
    Laurent D; Petersen KF; Russell RR; Cline GW; Shulman GI
    Am J Physiol; 1998 Jan; 274(1):E130-8. PubMed ID: 9458758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.